ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2023

C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma.

Andreas K Buck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.